Welcome!

This site serves to publish MAXimum HIGH TECH information, historical information, and information that is, for the most part, not available at any other website.

***LATEST ARTICLE***
Anavex AD OLE Results - Blarcamesine vs Donepezil
Anavex recently announced their long term results(192 weeks) from their Alzheimer's Disease open label trial. We have an interesting article comparing the Blarcamesine results to the standard of care Donepezil at 192 weeks.! This is an important reference because there is no placebo data out at 192 weeks. ---Max

Be sure to check out similar articles by Piotr Pietrzkiewicz at his Bio_oko patreon blog. ---Max

Other Articles

Additionally, we have an article comparing the ADAS-Cog results of the four Alzheimer's drugs - Aducanumab, Blarcamesine, Donanemab and Lecanemab!

For Parkinson's Disease, an efficacy comparison of Annovis's drug and the Anavex drug.